Yamasaki Shinya, Hashimoto Yusuke, Takigami Junsei, Terai Shozaburo, Mera Hisashi, Nakamura Hiroaki, Wakitani Shigeyuki
Department of Orthopaedic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka-City, Osaka 545-8585, Japan.
Department of Orthopaedic Surgery, Osaka City General Hospital, 2-13-22 Miyakojima-hondori, Mikakojima-ku, Osaka-City, Osaka 534-0021, Japan.
Regen Ther. 2015 Nov 26;2:42-48. doi: 10.1016/j.reth.2015.10.003. eCollection 2015 Dec.
The purpose of this study was to assess the direct injection of bone marrow-derived mesenchymal stem cells (BMSCs) suspended in hyaluronic acid (HA) combined with drilling as a treatment for chondral defects in a canine model.
Tibial bone marrow was aspirated, and BMSCs were isolated and cultured. One 8.0-mm diameter chondral defect was created in the femoral groove, and nine 0.9-mm diameter holes were drilled into the defect. BMSCs (2.14 × 10 cells) suspended in HA were injected into the defect. HA alone was injected into a similar defect on the contralateral knee as a control. Animals were sacrificed at 3 and 6 months.
Although the percentage of coverage assessed macroscopically was significantly better at 6 months than at 3 months in both the BMSC (p = 0.02) and control (p = 0.001) groups, there were no significant differences in the International Cartilage Repair Society grades. The Wakitani histological score was significantly better at 6 months than at 3 months in the BMSC and control groups. While the control defects were mostly filled with fibrocartilage, several of the defects in the BMSC group contained hyaline-like cartilage. The mean Wakitani scores of the BMSC group improved from 7.0 ± 1.0 at 3 months to 4.6 ± 0.9 at 6 months, and those of the control group improved from 9.4 ± 1.2 to 6.0 ± 0.6. The BMSC group showed significantly better regeneration than the control group at 3 months (p = 0.04), but the difference at 6 months was not significant (p = 0.06).
The direct injection of BMSCs in HA combined with drilling enhanced cartilage regeneration.
本研究的目的是评估在犬类模型中,将悬浮于透明质酸(HA)中的骨髓间充质干细胞(BMSCs)直接注射并联合钻孔治疗软骨缺损的效果。
抽取胫骨骨髓,分离并培养BMSCs。在股骨沟制造一个直径8.0毫米的软骨缺损,并在缺损处钻九个直径0.9毫米的孔。将悬浮于HA中的BMSCs(2.14×10个细胞)注射到缺损处。仅将HA注射到对侧膝关节的类似缺损处作为对照。在3个月和6个月时对动物实施安乐死。
尽管在BMSC组(p = 0.02)和对照组(p = 0.001)中,6个月时宏观评估的覆盖百分比均显著优于3个月时,但国际软骨修复协会分级并无显著差异。在BMSC组和对照组中,Wakitani组织学评分在6个月时显著优于3个月时。对照组缺损大多由纤维软骨填充,而BMSC组的一些缺损含有类透明软骨。BMSC组的平均Wakitani评分从3个月时的7.0±1.0提高到6个月时的4.6±0.9,对照组则从9.4±1.2提高到6.0±0.6。BMSC组在3个月时的再生效果显著优于对照组(p = 0.04),但在6个月时差异不显著(p = 0.06)。
将BMSCs直接注射到HA中并联合钻孔可增强软骨再生。